HOME Research Insight Market Leader - Endoscope Reprocessing Market

Market Leader - Endoscope Reprocessing Market

The global endoscope reprocessing market is projected to reach USD 2.15 Billion by 2022 from an estimated USD 1.42 Billion in 2017, at a CAGR of 8.6%.

Endoscope reprocessing caters to a diverse group of end users, namely, hospitals, ambulatory surgery centers, and other end users such as diagnostic centers, mobile endoscopy facilities, and office endoscopy centers.

In 2017, the endoscope reprocessing market was dominated by Advanced Sterilization Products (ASP) (US), Cantel Medical Corporation (US), and Laboratories Anios (France), which together accounted for a significant market share.

Advanced Sterilization Products (ASP) accounted for the largest share of the endoscope reprocessing market. The company has been operating in the market for about 30 years and is engaged developing and manufacturing innovative infection prevention solutions. ASP focuses on participating in webinars and conferences to increase awareness as well as showcase its endoscope reprocessing products. For instance, in November 2015, ASP showcased its infection prevention solutions at the 16th World Sterilization Congress of the World Forum for Hospital Sterile Supply (WFHSS) held in France. The firm has a strong geographical presence with its distribution network and authorized sales representatives present in the US, Europe, APAC, and Africa.

Cantel Medical Corporation dominated the global endoscope reprocessing market with the second largest market share. The company’s endoscopy segment generated revenue of USD 341.8 million in 2016; this has helped the company reinforce its position among all key players in the endoscope reprocessing market. The company witnessed an increase of 37.4% in the sales of its products in the endoscopy business in 2016 compared to 2015. The firm’s heavy R&D spending— USD 15.4 million in 2016— allows the company to develop and enhance its products. For instance, in 2015, Cantel Medical launched MEDIVATORS ADVANTAGE PLUS Pass-Thru endoscope reprocessor, MEDIVATORS ISA endoscope reprocessor, and MEDIVATORS RAPIDAER endoscope reprocessor for the European and APAC markets. Inorganic growth through acquisitions is a key focus for the company. For instance, in April 2017, Cantel Medical acquired endoscopy business assets from C.R. Kennedy & Company Pty. Ltd. (Australia). This acquisition helped the company to expand direct sales operation in Australia.

Laboratories Anios is a prominent and well-established player in the endoscope reprocessing market. The company focuses on inorganic strategies to ensure market growth. For instance, in 2016, Anios Laboratories acquired Endoclear (Brazil) to expand its presence in an emerging market like Brazil. In addition, the company acquired Soluscope in 2014. The company also puts emphasis on constant innovation, in the recent years the company has launched equipment and supplies such as the IT Soluscope, Soluscope Trolley & Rack, and Anios’Clean Excel D among others.

The others players of the endoscope reprocessing market include Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others.

Related Reports:

Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2022

Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports